4.025USD0.00%Mkt Cap: 503.18M USDP/E: —Last update: 2026-06-01
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a su…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap503.18M USD
Enterprise Value437.16M USD
Revenue (TTM)50.27M USD
Gross Profit25.99M USD
Net Income (TTM)-83.78M USD
Revenue/Share0.4420 USD
Last Price4.025 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees147
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.93
PEG—
EV/EBITDA-7.90
EV/Revenue8.70
P/S10.03
P/B-14.67
EPS (TTM)-0.61
EPS (Forward)-0.45
52W Range
2.64028% of range7.550
52W High7.550 USD
52W Low2.640 USD
Profitability
Gross Margin58.35%
Oper. Margin-29.10%
EBITDA Margin-110.09%
Profit Margin-188.09%
ROE248.90%
ROA-52.23%
Growth
Revenue Growth65.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-52.43M USD
CapEx (TTM)562.00K USD
FCF Margin-51.10%
FCF Yield-5.11%
Net Debt-67.15M USD
Net Debt/EBITDA1.21
Balance Sheet
Debt/Equity-1.26
Current Ratio4.10
Quick Ratio3.70
Book Value/Sh-0.2740 USD
Cash/Share0.8830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)8.889 USD
Target Range6.000 USD – 11.00 USD
# Analysts9
Ownership
Shares Out.125.45M
Float114.68M
Insiders3.10%
Institutions60.59%
Short Interest
Short Ratio9.3d
Short % Float12.55%
Short % Out.11.98%
Shares Short15.03M
Short (prev mo.)15.52M
Technical
SMA 504.149 (-3.0%)
SMA 2004.877 (-17.5%)
Beta1.50
S&P 52W Chg27.94%
Avg Vol (30d)1.55M
Avg Vol (10d)2.08M
Technical Indicators
RSI (14)44.4
MACD-0.0306
MACD Signal-0.0033
MACD Hist.-0.0273
BB Upper4.497 USD
BB Middle4.193 USD
BB Lower3.889 USD
BB Width14.52%
ATR (14)0.1873 USD
Vol Ratio (20d)0.51x